6/26/2025

Zoetis delivered revenue and adjusted EPS above Wall Street expectations in Q1, driven by strong organic operational growth across its diverse portfolio. Management pointed to particularly robust performance internationally, with the Simparica, dermatology, and osteoarthritis pain franchises fueling momentum. CEO Kristin Peck highlighted, “our innovative companion animal portfolio grew 9% operationally, fueled by sustained demand for our diverse, market-leading franchises.” Despite ongoing macro

Source: Yahoo

6/25/2025

Zoetis Inc. (NYSE:ZTS) is one of the 10 Worst Aggressive Growth Stocks to Buy According to Short Sellers. On June 18, Stifel analyst Jonathan Block downgraded Zoetis Inc. (NYSE:ZTS)’s stock to “Hold” from “Buy,” reducing the price objective to $160 from $165. The firm warned that revenue growth might fall short of Wall Street expectations over the […]

Source: Yahoo

6/25/2025

I remain positive on Phibro's long-term prospects and would look to buy on dips, as structural improvements appear sustainable. Read more on PAHC stock here.

Source: SeekingAlpha

6/20/2025

Zoetis Inc. stock outperforms competitors on strong trading day

Source: MarketWatch

6/20/2025

ADRNY vs. CLX: Which Stock Is the Better Value Option?

Source: Yahoo

6/20/2025

SGIOY vs. ZTS: Which Stock Is the Better Value Option?

Source: Yahoo

6/20/2025

June S&P 500 E-Mini futures (ESM25) are trending up +0.15% this morning as cash trading resumed after the Juneteenth holiday, with investors digesting the White House’s signal that President Trump would delay a decision to launch strikes against Iran.

Source: Yahoo

6/19/2025

Stifel Financial downgraded Zoetis stock on Wednesday, causing the animal health company’s shares to fall 4% on the news. The analyst downgrade created a possible long straddle for options investors. The question is whether it’s the best strategy.

Source: Yahoo

6/19/2025

The most talked about and market moving research calls around Wall Street are now in one place. Here are today’s research calls that investors need to know, as compiled by The Fly. Top 5 Upgrades: Cantor Fitzgerald upgraded Analog Devices (ADI) to Overweight from Neutral with a price target of $270, up from $250. Analog Devices is a “best-in-class” analog company, with “outsized” industrial exposure which is preferential into the upcycle, the firm tells investors in a research note. Argus upgrad

Source: Yahoo

6/18/2025

Zoetis (ZTS) closed at $155.06 in the latest trading session, marking a -4.09% move from the prior day.

Source: Yahoo

6/18/2025

Health care stocks were decreasing late Wednesday afternoon, with the NYSE Health Care Index down 0.

Source: Yahoo

6/18/2025

It’s shaping up to be a dog-eat-dog world for Zoetis as the maker of veterinary medicine faces stiff competition in the animal health market. Zoetis was created in 2013 after splitting off from Pfizer’s animal health division. In fact, Zoetis has proven to be even more profitable than Merck’s animal health division as of late.

Source: Yahoo

6/18/2025

U.S. equities rose at midday ahead of the latest announcement from the Federal Reserve, as President Donald Trump again called on Fed Chair Jerome Powell to cut interest rates.

Source: Yahoo

6/18/2025

This is our monthly dashboard series on Healthcare and Pharma stocks. Read the full analysis here, and which 10 healthcare stocks were cheaper than their peers in June 2025.

Source: SeekingAlpha

6/18/2025

Investing.com -- Stifel downgraded Zoetis (NYSE:ZTS) to Hold from Buy, warning that revenue growth could fall short of Wall Street expectations in the next two years as competition intensifies across key product categories.

Source: Yahoo

6/17/2025

Zoetis Inc. stock outperforms competitors despite losses on the day

Source: MarketWatch

6/16/2025

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Source: Yahoo

6/13/2025

Zoetis Inc. stock underperforms Friday when compared to competitors

Source: MarketWatch

6/12/2025

Zoetis (ZTS) reached $168.82 at the closing of the latest trading day, reflecting a +1.5% change compared to its last close.

Source: Yahoo

6/12/2025

Zoetis Inc. stock underperforms Thursday when compared to competitors despite daily gains

Source: MarketWatch